PortfoliosLab logo
BNS vs. NVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BNS and NVS is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

BNS vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Bank of Nova Scotia (BNS) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

BNS:

0.65

NVS:

0.64

Sortino Ratio

BNS:

1.11

NVS:

1.04

Omega Ratio

BNS:

1.15

NVS:

1.14

Calmar Ratio

BNS:

0.44

NVS:

0.69

Martin Ratio

BNS:

1.78

NVS:

1.48

Ulcer Index

BNS:

7.54%

NVS:

9.24%

Daily Std Dev

BNS:

17.61%

NVS:

19.61%

Max Drawdown

BNS:

-63.79%

NVS:

-41.72%

Current Drawdown

BNS:

-17.78%

NVS:

-6.85%

Fundamentals

Market Cap

BNS:

$62.98B

NVS:

$214.69B

EPS

BNS:

$3.51

NVS:

$6.38

PE Ratio

BNS:

14.32

NVS:

17.04

PEG Ratio

BNS:

1.27

NVS:

1.31

PS Ratio

BNS:

2.18

NVS:

4.10

PB Ratio

BNS:

1.15

NVS:

5.67

Total Revenue (TTM)

BNS:

$26.20B

NVS:

$52.86B

Gross Profit (TTM)

BNS:

$26.20B

NVS:

$39.86B

EBITDA (TTM)

BNS:

$2.76B

NVS:

$21.88B

Returns By Period

In the year-to-date period, BNS achieves a -3.63% return, which is significantly lower than NVS's 15.73% return. Over the past 10 years, BNS has underperformed NVS with an annualized return of 4.49%, while NVS has yielded a comparatively higher 6.50% annualized return.


BNS

YTD

-3.63%

1M

10.49%

6M

-4.00%

1Y

11.27%

5Y*

12.06%

10Y*

4.49%

NVS

YTD

15.73%

1M

5.13%

6M

5.79%

1Y

10.30%

5Y*

10.23%

10Y*

6.50%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BNS vs. NVS — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BNS
The Risk-Adjusted Performance Rank of BNS is 7171
Overall Rank
The Sharpe Ratio Rank of BNS is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of BNS is 6969
Sortino Ratio Rank
The Omega Ratio Rank of BNS is 6868
Omega Ratio Rank
The Calmar Ratio Rank of BNS is 7171
Calmar Ratio Rank
The Martin Ratio Rank of BNS is 7171
Martin Ratio Rank

NVS
The Risk-Adjusted Performance Rank of NVS is 7171
Overall Rank
The Sharpe Ratio Rank of NVS is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of NVS is 6767
Sortino Ratio Rank
The Omega Ratio Rank of NVS is 6767
Omega Ratio Rank
The Calmar Ratio Rank of NVS is 7878
Calmar Ratio Rank
The Martin Ratio Rank of NVS is 6969
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BNS vs. NVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Bank of Nova Scotia (BNS) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current BNS Sharpe Ratio is 0.65, which is comparable to the NVS Sharpe Ratio of 0.64. The chart below compares the historical Sharpe Ratios of BNS and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

BNS vs. NVS - Dividend Comparison

BNS's dividend yield for the trailing twelve months is around 6.07%, more than NVS's 3.67% yield.


TTM20242023202220212020201920182017201620152014
BNS
The Bank of Nova Scotia
6.07%5.84%6.40%6.40%4.02%4.94%3.54%5.10%3.75%3.98%6.63%4.11%
NVS
Novartis AG
3.67%3.84%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%

Drawdowns

BNS vs. NVS - Drawdown Comparison

The maximum BNS drawdown since its inception was -63.79%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for BNS and NVS. For additional features, visit the drawdowns tool.


Loading data...

Volatility

BNS vs. NVS - Volatility Comparison

The current volatility for The Bank of Nova Scotia (BNS) is 3.83%, while Novartis AG (NVS) has a volatility of 6.90%. This indicates that BNS experiences smaller price fluctuations and is considered to be less risky than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

BNS vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between The Bank of Nova Scotia and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


7.00B8.00B9.00B10.00B11.00B12.00B13.00B14.00BJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
9.26B
13.62B
(BNS) Total Revenue
(NVS) Total Revenue
Values in USD except per share items